Fierce Pharma

Fierce Pharma is one of the most widely read trade publications in the pharmaceutical industry, delivering breaking news, analysis, and intelligence to professionals across drug development, commercialisation, and business strategy.

Published by Questex, the platform covers the full breadth of the pharmaceutical and biotech landscape, tracking FDA approvals, clinical trial outcomes, mergers and acquisitions, patent cliffs, and executive appointments as they happen. Its free daily newsletter has built a substantial subscriber base among pharma executives, investors, regulatory affairs professionals, and industry analysts who rely on it to stay current in a fast-moving sector.

Beyond its flagship publication, Fierce Pharma operates as part of the wider Fierce Media network, which includes verticals covering biotech, medtech, healthcare finance, and clinical research. This network structure allows readers to follow news across adjacent sectors from a single trusted source. The editorial team is based primarily in the United States, and coverage spans global markets including Europe, Asia-Pacific, and emerging biopharma hubs.

The publication is particularly well regarded for its coverage of Big Pharma pipeline movements, patent expiry analysis, and the competitive dynamics between branded and generic manufacturers. It also tracks the growing biosimilars market and the evolving regulatory environment under agencies such as the FDA and EMA.

Further information is available at fiercepharma.com.